Simethicone

Publication Details

Estimated reading time: 1 minute

CASRN: 8050-81-5

image 134990626 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

Although no data are available on the use of simethicone during breastfeeding, it is not absorbed orally. Therefore, it cannot be transferred to breastmilk.[1] It is also used safely given directly to infants.[2,3] No special precautions are required.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

References

1.
Mahadevan U, Kane S. American Gastroenterological Association Institute Technical Review on the Use of Gastrointestinal Medications in Pregnancy. Gastroenterology 2006;131:283-311 [PubMed: 16831611]
2.
Hagemann TM. Gastrointestinal medications and breastfeeding. J Hum Lact 1998;14:259-62 [PubMed: 10205441]
3.
Savino F, Pelle E, Palumeri E, et al. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: A prospective randomized study. Pediatrics 2007;119:e124-30 [PubMed: 17200238]

Substance Identification

Substance Name

Simethicone

CAS Registry Number

8050-81-5

Drug Class

Breast Feeding

Lactation

Milk, Human

Gastrointestinal Drugs

Antifoaming Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.